Current position:Home >Product >
Benzoic acid, 2-[[5-(4-hydroxy-3,5-dimethoxyphenyl)-1-oxo-2,4-pentadienyl]amino]-, (E,E)-
Benzoic acid, 2-[[5-(4-hydroxy-3,5-dimethoxyphenyl)-1-oxo-2,4-pentadienyl]amino]-, (E,E)-(101618-52-4)
- Name: Benzoic acid, 2-[[5-(4-hydroxy-3,5-dimethoxyphenyl)-1-oxo-2,4-pentadienyl]amino]-, (E,E)-
- Synonyms:
- Molecular Formula:C20H19NO6
- Molecular Weight:
- CAS Registry Number:101618-52-4
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 101618-45-5/2-Propenamide, N-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethyl]-3-(4-hydroxy- 3,5-dimethoxyphenyl)-, (E)-
- 101618-47-7/Benzoic acid, 2-[[3-(4-hydroxy-3,5-dimethoxyphenyl)-1-oxo-2-propenyl]amino]-, (E)-
- 101618-48-8/2-Propenamide, N-[2-[4-(diphenylmethyl)-1-piperazinyl]ethyl]-3-(3,4,5-trimethoxyphenyl)-, (E)-
- 101618-49-9/2,4-Pentadienamide, N-[2-[4-(diphenylmethyl)-1-piperazinyl]ethyl]-5-(4-hydroxy-3,5-dimethoxy phenyl)-, (E,E)-
- 101618-50-2/2,4-Pentadienamide, N-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethyl]-5-(4-hydroxy- 3,5-dimethoxyphenyl)-, (E,E)-
- 101618-52-4/Benzoic acid, 2-[[5-(4-hydroxy-3,5-dimethoxyphenyl)-1-oxo-2,4-pentadienyl]amino]-, (E,E)-
- 101618-54-6/2,4-Pentadienamide, N-[2-[4-(diphenylmethyl)-1-piperazinyl]ethyl]-5-(3,4,5-trimethoxyphenyl)-, (E,E)-
- 101618-67-1/2-Propenamide, N-[3-(diphenylmethoxy)propyl]-3-(4-hydroxy-3-methoxyphenyl)-, (E)-
- 101618-68-2/2-Propenamide, 3-(3,4-dimethoxyphenyl)-N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-, (E)-
- 101618-69-3/2-Propenamide, 3-(3,4-dimethoxyphenyl)-N-[4-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-diox o-7H-purin-7-yl)butyl]-, (E)-
- 101618-71-7/2-Propenamide, 3-(3,4-dimethoxyphenyl)-N-[2-(diphenylmethoxy)ethyl]-, (E)-
- 101618-72-8/2-Propenamide, N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-3-(4-hydroxy-3,5-dimethoxy phenyl)-, (E)-
- 101618-73-9/Piperazine, 1-[2-(diphenylmethoxy)ethyl]-4-[3-(4-hydroxy-3,5-dimethoxyphenyl)-1-ox o-2-propenyl]-, (E)-
- 101618-75-1/2-Propenamide, N-[2-(diphenylmethoxy)ethyl]-3-(4-hydroxy-3,5-dimethoxyphenyl)-, (E)-
- 101618-76-2/2,4-Pentadienamide, 5-(3,4-dihydroxyphenyl)-N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-, (E,E)-
- 101618-44-4/2,4-Pentadienamide, N-[2-[4-(2-aminobenzoyl)-1-piperazinyl]ethyl]-5-(3,4-dimethoxyphenyl)-, (E,E)-
- 101618-43-3/2,4-Pentadienamide, 5-(3,4-dimethoxyphenyl)-N-[3-[4-(diphenylmethyl)-1-piperazinyl]propyl]-, (E,E)-
- 101618-40-0/2,4-Pentadienamide, 5-(3,4-dihydroxyphenyl)-N-[3-[4-(diphenylmethyl)-1-piperazinyl]propyl]-, (E,E)-
- 101618-36-4/2,4-Pentadienamide, 5-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-methyl-1-piperazinyl)ethyl]-, (E,E)-
- 101618-33-1/2-Propenamide, 3-(3,4-dihydroxyphenyl)-N-[3-[4-(diphenylmethyl)-1-piperazinyl]propyl]-, (E)-
- 101618-32-0/Benzamide, 2-amino-N-[4-[[3-(4-hydroxy-3-methoxyphenyl)-1-oxo-2-propenyl]amino] butyl]-, (E)-
- 101618-30-8/9,11,13-Hexadecatrienamide, N-[4-[[5-(3,4-dimethoxyphenyl)-1-oxo-2,4-pentadienyl]amino]butyl]-, (E,E,Z,Z,Z)-
- 101618-28-4/2,4-Pentadienamide, 5-(3,4-dimethoxyphenyl)-N-(4-hydroxyphenyl)-, (E,E)-
- 101618-27-3/2,4-Pentadienamide, N-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethyl]-5-(3,4-dimeth oxyphenyl)-, (E,E)-
- 101618-26-2/Benzoic acid, 2-[[5-(3,4-dimethoxyphenyl)-1-oxo-2,4-pentadienyl]amino]-, (E,E)-
- 101618-24-0/2,4-Pentadienamide, 5-(3,4-dihydroxyphenyl)-N-[2-[4-(diphenylmethyl)-1-piperazinyl]ethyl]-, (E,E)-
- 101618-23-9/Piperazine, 1-[5-(3,4-dihydroxyphenyl)-1-oxo-2,4-pentadienyl]-4-(diphenylmethyl)-, (E,E)-
- 101618-22-8/2,4-Pentadienamide, 5-(3,4-dihydroxyphenyl)-N-(4-hydroxyphenyl)-, (E,E)-
- 101618-21-7/Benzoic acid, 2-[[5-(3,4-dihydroxyphenyl)-1-oxo-2,4-pentadienyl]amino]-, (E,E)-
- 101618-66-0/2-Propenamide, N-[2-(diphenylmethoxy)ethyl]-3-(4-hydroxy-3-methoxyphenyl)-, (E)-